Simris Group
0.10 SEK
-5.19 %
Less than 1K followers
SIMRIS B
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Simris Group
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.8 | 1.0 | 2.9 | 0.2 | 0.7 | 0.5 | 0.3 | 1.6 |
| EBITDA | -3.0 | -3.2 | -17.6 | -3.7 | -3.0 | -3.6 | -5.2 | -15.5 |
| EBIT | -6.6 | -9.2 | -34.7 | -7.3 | -6.7 | -7.2 | -8.4 | -29.6 |
| EBIT-% | -858.4 % | -952.6 % | -1,201.0 % | -4,556.3 % | -969.6 % | -1,489.6 % | -2,957.5 % | -1,830.5 % |
| Profit before taxes | -7.2 | -10.7 | -38.2 | -6.8 | -8.2 | -7.1 | -7.9 | -30.0 |
| Net income | -6.4 | -9.7 | -34.6 | -6.0 | -7.3 | -6.3 | -7.2 | -26.8 |